Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Acta Medica Martiniana

The Journal of Comenius University in Bratislava

3 Issues per year

Open Access
See all formats and pricing
More options …

Genetics of Psoriasis - Short Resume

V. Valentova / P. Galajda / M. Pec / M. Mokan / J. Pec
  • Clinic of Dermatovenerology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovak Republic
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2011-06-03 | DOI: https://doi.org/10.2478/v10201-011-0001-0

Genetics of Psoriasis - Short Resume

Psoriasis is a disease with a genetic background (4). Several psoriasis susceptibility loci (PSORS) have been found on various chromosomes: PSORS1 on 6p21.3, PSORS2 on 17q, PSORS3 on 4q, PSORS4 on 1q21, PSORS5 on 3q21, PSORS6 on 19p, PSORS7 on 1p, PSORS8 on 16q, PSORS9 on 4q31, PSORS10 on 18p11, PSORS11 on 5q31-q33 and PSORS12 on 20q13. (27). However, the exact genes and their functions, or their respective malfunctions, in psoriasis and arthritis have not been unambiguously identified. Recently, it has been argued that PSORS1 may indeed be the HLA-Cw*06 allele encoding the HLA-Cw6 molecule (35).

Psoriasis is a chronic inflammatory disease of skin that also often affects joints and nails. This disorder is characterized by hyperproliferation of keratinocytes, activation of angiogenesis, vasodilatation and mainly by lymphocyte infiltration of dermis and epidermis (45). The process of maturation of keratinocytes is accelerated and thus not quite terminated. Psoriatic lesion appears on skin.

Skin manifestations are typically red bounded areas of different size and shape with characteristic silvery scales (9). Lesions appear mostly on the skin of elbows and knees, scalp including genitals. Individual manifestations differ in size and severity from localized lesions to whole body involvement. Very often psoriasis affects nails of hands and feet. It can also cause inflammatory changes on joints, named as psoriatic arthritis. Similarly to rheumatoid arthritis and sclerosis multiplex, psoriasis is classified as an immune mediated inflammatory disorder. Those disorders are characterized by chronic progression of an inflammatory process and important role of TNF alpha. Because of the role of TNF alpha in pathogenesis, we can use its inhibitors in therapy. It also affects progress of different comorbidities such as diabetes mellitus 2 and cardiovascular problems (21). Patients with psoriasis have often other risk factors for atherosclerosis such as lipid metabolism disorders and overweight (37).

Keywords: psoriasis; PSORS; HLA-Cw6

  • Asumalahti K, Veal C, Laitinen T, Suomela S, Allen M, Elomaa O, Moser M, De Cid R, Ripatti S, Vorechovsky I, Marcusson JA, Nakagawa H, Lazaro C, Estivill X, Capon F, Novelli G, Saarialho-Kere U, Barker J, Trembath R, Kere J. Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus. Hum Mol Gene 2002; 11:589-597CrossrefGoogle Scholar

  • Allen MH, Veal C, Faassen A, Powis SH, Vaughan RW, Trembath RC, Barker JN. A non-HLA gene within the MHC in psoriasis. Lancet 1999; 353:1589-90Google Scholar

  • Asadullah K, Eskdale J, Wiese A, Gallagher G, Friedrich M, Sterry W. Interleukin-10 promoter polymorphism in psoriasis. J Invest Dermatol 2001; 116:975-978Google Scholar

  • Bhalerao J, Bowcock AM. The genetics of psoriasis: a complex disorder of the skin and immune system. Human molecular genetics 1998; 7:1537-45CrossrefPubMedGoogle Scholar

  • Bos JD, De Rie MA, Teunissen MB, Piskin G. Psoriasis: dysregulation of innate immunity. Br J Dermatol. 2005; 152:1098-107Google Scholar

  • Bowcock AM, Barker JN. Genetics of psoriasis: the potential impact on new therapies. J Am Acad Dermatol 2003; 49:51-56Google Scholar

  • Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez-Vina MA, Menter A. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 2001; 10:1793-805CrossrefPubMedGoogle Scholar

  • Brandrup F, Holm N, Grunnet N, Henningsen K, Hansen HE. Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution. Acta Dermatol 1982; 62:229-36.Google Scholar

  • Braun-Falco O, Plewig G, Wolff H. Dermatológia a venerológia 1. slov. a čes. vyd. Martin, Vydavateľstvo Osveta 2001; 1475s.Google Scholar

  • Campalani E, Barker JNWN. The Clinical Genetics of Psoriasis. Current Genomics 2005; 6:51-60CrossrefGoogle Scholar

  • Capon F, Munro M, Barker J, Trembath R. Searching for the major histocompatibility complex psoriasis susceptibility gene. J Invest Dermatol 2002; 118:745-751CrossrefPubMedGoogle Scholar

  • Capon F, Novelli G, Semprini S, Clementi M, Nudo M, Vultaggio P, Mazzanti C, Gobello T, Botta A, Fabrizi G, Dallapiccola B. Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol 1999; 112:32-35CrossrefGoogle Scholar

  • Cookson WOCM, Bowcock AC, Harper JI, Moffat MF. The immunogenetics of inflammatory skin disease. In: Bos JD editor. Skin immune system (SIS): Cutaneous immunology and clinical immunodermatology. 3rd ed. Boca Raton (FL):CRC Press 2005; pp 55-73Google Scholar

  • Duffy DL, Spelman LS, Martin LG. Psoriasis in Australian twins. J Am Acad Dermatol 1993; 29:428-434CrossrefPubMedGoogle Scholar

  • Elder JT. PSORS1: linking genetics and immunology. J Invest Dermatol 2006; 126:1250-6Google Scholar

  • Enlund F, Samuelsson L, Enerback C, Inerot A, Wahlstrom J, Yhr M, Torinsson A, Riley J, Swanbeck G, Martinsson T. Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden. Eur J Hum Genet 1999; 7:783-790CrossrefGoogle Scholar

  • Foerster J, Nolte I, Schweiger S, Ehlert C, Bruinenberg M, Spaar K, van der Steege G, Mulder M, Kalscheuer V, Moser B, Kijas Z, Seeman P, Ständer M, Sterry W, te Meerman G. Evaluation of the IRF-2 gene as a candidate for PSORS3. J Invest Dermatol 2004; 122:61-4Google Scholar

  • Halsall JA, Osborne JE, Pringle JH, Hutchinson PE. Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis. Pharmacogenet Genomics 2005; 15:349-55Google Scholar

  • Hardas BD, Zhao X, Zhang J, Longqing X, Stoll S, Elder JT. Assignment of psoriasin to human chromosomal band 1q21: coordinate overexpression of clustered genes in psoriasis. J Invest Dermatol 1996; 106:753-8Google Scholar

  • Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13:450-456CrossrefPubMedGoogle Scholar

  • Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32:982-986PubMedCrossrefGoogle Scholar

  • Henseler T, Koch F, Westphal E. Presence of HLA- DR7 in type I psoriasis. J Invest Dermatol 1992; 98:607Google Scholar

  • Henseler T. The genetics of psoriasis. J Am Acad Dermatol 1997; 37:S1-S11PubMedCrossrefGoogle Scholar

  • Hensen P, Asadullah K, Windemuth C, Rüschendorf F, Hüffmeier U, Ständer M, Schmitt-Egenolf M, Wienker TF, Reis A, Traupe H. Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis. Br J Dermatol. 2003; 149:381-5.Google Scholar

  • Karason A, Gudjonsson JE, Jónsson HH, Hauksson VB, Runarsdottir EH, Stefansson K, Valdimarsson H, Gulcher JR. Genetics of psoriasis in Iceland: evidence for linkage of subphenotypes to distinct loci. J Invest Dermatol 2005; 124:1177-85CrossrefPubMedGoogle Scholar

  • Karason A, Gudjonsson JE, Upmanyu R, Antonsdottir AA, Hauksson VB, Runasdottir EH, Jonsson HH, Gudbjartsson DF, Frigge ML, Kong A, Stefansson K, Valdimarsson H, Gulcher JR. A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am J Hum Genet 2003; 72:125-131Google Scholar

  • Kingo K, Mössner R, Rätsep R, Raud K, Krüger U, Silm H, Vasar E, Reich K, Kõks S. Association analysis of IL20RA and IL20RB genes in psoriasis. Genes Immun 2008; 9:445-51CrossrefGoogle Scholar

  • Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64:303-6Google Scholar

  • Krueger JG, Ellis CN. Psoriasis-recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 2005; 53:94-100Google Scholar

  • Leder RO and Farber EM. The variable incidence of psoriasis in sub-saharan Africa. Int J Dermatol 1997; 36:911-919PubMedGoogle Scholar

  • Lee YA, Ruschendorf F, Windemuth C, Schmitt-Egenolf M, Stadelmann A, Nurnberg G, Stander M, Wienker TF, Reis A, Traupe H. Genomewide scan in German families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. Am J Hum Genet 2000; 67:1020-1024Google Scholar

  • Li Y, Begovich AB. Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis. Semin Immunol 2009; 21:318-27CrossrefPubMedGoogle Scholar

  • Marcos CY, Fernandez-Vina MA, Barnes R. et al. HLA-B and HLA-C genes in familial psoriasis vulgaris (PV): evidence for genetic heterogeneity. Hum Immunol 1997; 55:51Google Scholar

  • Mechtcheriakova D, Wlachos A, Sobanov J, Kopp T, Reuschel R, Bornancin F, Cai R, Zemann B, Urtz N, Stingl G, Zlabinger G, Woisetschlăger M, Baumruker T, Billich A. Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell Signal 2007; 19:748-60CrossrefGoogle Scholar

  • Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, Lenk W, Westphal E, Guo SW, Christophers E, Voorhees JJ, Elder JT. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Molec Genet 1997; 6:1349-56Google Scholar

  • Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S, Weichenthal M, Abecasis GR, Lim HW, Christophers E, Voorhees JJ, Elder JT. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006; 78:827-51Google Scholar

  • Naldi L, Chatenoud I, Linder D, Belloni FA, Peserico A, Virgili AR, Bruni PL, Ingordo V, Lo Scocco G, Solaroli C, Schena D, Barba A, Di Ladro A, Pezzarossa E, Arcangeli F, Gianni C, Betti R, Carli P, Farris A, Barbino GF, La Vecchia C. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case control study. J Invest Dermatol 2005; 125:61-67PubMedCrossrefGoogle Scholar

  • Nickoloff BJ. The immunologic and genetic basis of psoriasis. Arch Dermatol 1999; 135:1104-10Google Scholar

  • Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003; 171:3262-9Google Scholar

  • Oudot T, Lesueur F, Guedj M, de Cid R, McGinn S, Heath S, Foglio M, Prum B, Lathrop M, Prud'homme JF, Fischer J. An Association Study of 22 Candidate Genes in Psoriasis Families Reveals Shared Genetic Factors with Other Autoimmune and Skin Disorders. J Invest Dermatol 2009; 129:2637-45Google Scholar

  • Quekenborn-Trinquet V, Fogel P, Aldana-Jammayrac O, Ancian P, Demarchez M, Rossio P, Richards HL, Kirby B, Nguyen C, Voegel JJ, Griffiths CE. Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity. Br J Dermatol 2005; 152:489-504Google Scholar

  • Sabat R, Philipp S, Höflich C, Kreutzer S, Wallace E, Asadullah K, Volk H-D, Sterry W, Wolk K. Immunopathogenesis of psoriasis. Exp Dermatol 2007; 16:779-798CrossrefPubMedGoogle Scholar

  • Samuelsson L, Enlund F, Torinsson A, Yhr M, Inerot A, Enerback C, Wahlstrom J, Swanbeck G, Martinsson T. A genome-wide search for genes predisposing to familial psoriasis by using a stratification approach. Hum Genet 1999; 105:523-529Google Scholar

  • Semprini S, Capon F, Tacconelli A, Giardina E, Orecchia A, Mingarelli R, Gobello T, Zambruno G, Botta A, Fabrizi G, Novelli G. Evidence for differential S100 gene over-expression in psoriatic patients from genetically heterogeneous pedigrees. Hum Genet 2002; 111:310-3PubMedCrossrefGoogle Scholar

  • Schön MP, Boehncke WH. Psoriasis. N Engl J Med 2005; 352:1899-912Google Scholar

  • Siroux V, Bouzigon E, Dizier MH, Pin I, Demenais F, Kauffmann F. Replication of association between ADAM33 polymorphisms and psoriasis. PLoS ONE 2008; 3:2448CrossrefGoogle Scholar

  • Stuart P, Nair RP, Abecasis GR, Nistor I, Hiremagalore R, Chia NV, Qin ZS, Thompson RA, Jenisch S, Weichenthal M, Janiga J, Lim HW, Christophers E, Voorhees JJ, Elder JT. Analysis of RUNX1 binding site and RAPTOR polymorphism in psoriasis: no evidence for association despite adequate power and evidence for linkage. J Med Genet 2006; 43:12-7Google Scholar

  • Suomela S, Kainu K, Onkamo P, Tiala I, Himberg J, Koskinen L, Snellman E, Karvonen SL, Karvonen J, Uurasmaa T, Reunala T, Kivikäs K, Jansén CT, Holopainen P, Elomaa O, Kere J, Saarialho-Kere U. Clinical associations of the risk alleles of HLA- Cw6 and CCHCR1*WWCC in psoriasis. Acta Derm Venereol 2007; 87:127-34Google Scholar

  • Tiilikainen A, Lassus A, Karvonen J, Vartiainen P, Julin M. Psoriasis and HLA-Cw6. Br J Dermatol. 1980; 102:179-84CrossrefGoogle Scholar

  • Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994; 264:1141-5Google Scholar

  • Trembath RC, Lee Clough R, Rosbotham JL, Jones AB, Camp RDR, Frodsham A, Browne J, Barber R, Terwilliger J, Lathrop GM, Barker JNWN. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997; 6:813-820Google Scholar

  • Veal CD, Clough RL, Barber RC, Mason S, Tillman D, Ferry B, Jones AB, Ameen M, Balendran N, Powis SH, Burden AD, Barker JNWN, Trembath RC. Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet 2001; 38:7-13Google Scholar

  • Villadsen LS, Schuurman J, Beurskens F, Dam TN, Dagnaes-Hansen F, Skov L, Rygaard J, Voorhorst-Ogink MM, Gerritsen AF, van Dijk MA, Parren PW, Baadsgaard O, van de Winkel JG. Resolution of psoriasis upon blockage of Il-15 biologic activity in a xenograft mouse model. J Clin Invest 2003; 112:1571-80Google Scholar

  • Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D, Scheuch H, Angel P, Tschachler E, Wagner EF. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nat 2005; 437:369-75Google Scholar

  • Zhang K, Li X, Yin G, Liu Y, Niu X, Hou R. Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder. Br J Dermatol 2008; 158:298-305Google Scholar

  • Zhang XJ, He PP, Wang ZX, Zhang J, Li YB, Wang HY, Wei SC, Chen SY, Xu SJ, Jin L, Yang S, Huang W. Evidence for a major psoriasis susceptibility locus at 6p21 (PSORS1) and a novel candidate region at 4q31 by genome-wide scan in Chinese hans. J Invest Dermatol 2002; 119:1361-6Google Scholar

  • Zhou X, Krueger JG, Kao MC, Lee E, Du F, Menter A, Wong WH, Bowcock AM; Novel mechanism of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 2003; 13:69-78Google Scholar

About the article

Published Online: 2011-06-03

Published in Print: 2011-03-01

Citation Information: Acta Medica Martiniana, ISSN (Print) 1335-8421, DOI: https://doi.org/10.2478/v10201-011-0001-0.

Export Citation

This content is open access.

Comments (0)

Please log in or register to comment.
Log in